Related by context. Frequent words. (Click for all words.) 71 Initiates Phase II 71 specific ZFP Nucleases 69 Receives Orphan Drug Designation 68 BioMarin develops 68 Files Shelf Registration Statement 68 developing Zerenex TM 68 http:/www.nabi.com 68 CPL Biologicals 68 ZFN TM 68 sanofi aventis GlaxoSmithKline 68 Presents Positive 67 please visit http:/www.supergen.com 67 Inc Therapeutic Competitors 67 leading lipid nanoparticle 67 Marcus Gronholm BP 67 Inc. Nasdaq IMGN 67 hepatitis C lupus 66 Nasdaq ENMD 66 GVAX cancer 66 VEGFR2 inhibitor 66 commercializing therapeutic 66 GVAX R 66 Inc. NASDAQ MBLX 66 addressing idiopathic pulmonary 66 FDA Accepts 66 www.combinatorx.com 66 Welcomes Analyst Initiation 66 www.vical.com 66 Inc. NASDAQ NVAX 66 By Neil Osterweil 65 Attracting Bullish Investors 65 http:/www.curagen.com 65 commercializes biotherapeutics 65 Emergent marketed 65 symbol TOMO 65 commercializes innovative biopharmaceuticals 65 commercialize phytocannabinoid based 65 Regulatory Disclosure 65 By JOHN MCCLAIN 65 Connetics Corporation 65 Nasdaq CRXL 65 Enrolls First 65 Cerus Corporation 65 non personalized allogeneic 65 By DAN MURTAUGH 65 Inc. NASDAQ TRGT 64 www.vivus.com 64 www.syntapharma.com 64 Jumps Higher 64 * Azixa 64 By TERRANCE HARRIS 64 By JENNY DIAL 64 By MARK CARREAU 64 fibrosis IPF 64 By RICK KRETZSCHMAR 64 www.pozen.com 64 By GlobeNewswire #/#/# 64 R sorafenib tablets 64 By JASON LAUGHLIN 64 Inc. Nasdaq SUPG 64 novel antibody therapeutics 64 www.dyax.com 64 By DEEPA BHARATH 64 By BEVERLY CORBELL 64 By MIKE SACCONE 64 Medarex logo 64 NASDAQ SNTA biopharmaceutical 64 PROFILE CO 64 THE ISSUER IS AUTHORITATIVE 64 Earnings Postmortem 64 Staff Writer jschramm@minotdailynews.com 64 Commences Phase 64 By MOISEKAPENDA BOWER 64 www.holliseden.com 64 Completes Enrollment 64 www.polymedix.com 64 NASDAQ CRXL 64 symbol SIRF 64 Initiates Phase 64 including nutritionals devices 64 By ERIC HANSON 64 BLOGS DISCUSSION FORUMS 63 Boozy nightKaty Perry 63 niobium oxides vanadium 63 By Thomas Gryta 63 By BRIAN MCTAGGART 63 CD#.# DOES NOT ENDORSE 63 Paris EURONEXT SAN 63 Antigen Express website 63 novel RNAi therapeutics 63 based pretargeting methods 63 By Megan Ainscow 63 By XiaoBing #-#-# 63 By RICHARD JUSTICE 63 By RUTH RENDON 63 submitted Biologics License 63 Potassium Chloride Sodium Ascorbate 63 Announces Initiation 63 YOUR LOCAL ANIMAL SHELTER 63 By Jason Kaneshiro 63 Biodefense Division